Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population

Cited in:

CrossRef

This article has been cited by:

1. 1
   Gemma Vart, Rita Banzi, Silvia Minozzi, Comparing participation rates between immunochemical and guaiac faecal occult blood tests: A systematic review and meta-analysis, Preventive Medicine, 2012,

   CrossRef

2. 2
   Sofie Van Roosbroeck, Sarah Hoeck, Guido Van Hal, Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: A comparison of two invitation strategies, Cancer Epidemiology, 2012,

   CrossRef

3. 3
   Germaine Wong, Kirsten Howard, Allison Tong, Jonathan C. Craig, Cancer Screening in People Who Have Chronic Disease: The Example of Kidney Disease, Seminars in Dialysis, 2011, 24, 1

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(142K)
   • References
4. 4
   Leo G.M. van Rossum, Anne F. van Rijn, Andre L.M. Verbeek, Martijn G.H. van Oijen, Robert J.F. Laheij, Paul Fockens, Jan B.M.J. Jansen, Eddy M.M. Adang, Evelien Dekker, Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: A cost-effectiveness analysis, International Journal of Cancer, 2011, 128, 8

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(319K)
   • References
5. 5
   Iradj Sobhani, Kazem Alzahouri, Idir Ghout, Delchier Jean Charles, Isabelle Durand-Zaleski, Cost-Effectiveness of Mass Screening for Colorectal Cancer: Choice of Fecal Occult Blood Test and Screening Strategy, Diseases of the Colon & Rectum, 2011, 54, 7, 876

   CrossRef

6. 6
   Aafke H.C. van Roon, Janneke A. Wilschut, Lieke Hol, Marjolein van Ballegooijen, Jacqueline C.I.Y. Reijerink, Hans 't Mannetje, Laura J.C. Kranenburg, Katharina Biermann, Anneke J. van Vuuren, Jan Francke, Alexandra C.M. van der Togt, Dik J.F. Habbema, Monique E. van Leerdam, Ernst J. Kuipers, Diagnostic Yield Improves With Collection of 2 Samples in Fecal Immunochemical Test Screening Without Affecting Attendance, Clinical Gastroenterology and Hepatology, 2011, 9, 4, 333

   CrossRef

7. 7
   Guido Van Hal, Sarah Hoeck, Sofie Van Roosbroeck, Screening for colorectal cancer: sense and sensibilities, European Journal of Cancer, 2011, 47, S156

   CrossRef

8. 8
   Germaine Wong, Kirsten Howard, Jeremy R Chapman, Allison Tong, Michael J Bourke, Andrew Hayen, Petra Macaskill, Richard L Hope, Narelle Williams, Anh Kieu, Richard Allen, Steven Chadban, Carol Pollock, Angela Webster, Simon D Roger, Jonathan C Craig, Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocol, BMC Public Health, 2011, 11, 1, 516

   CrossRef

9. 9
   Yasuhiro Oono, Yosuke Iriguchi, Yosuke Doi, Yasuhiro Tomino, Daisuke Kishi, Johji Oda, Satoshi Takayanagi, Masaru Mizutani, Tadashi Fujisaki, Akihiko Yamamura, Tozo Hosoi, Hiromi Taguchi, Mieko Kosaka, Pabel Delgado, A retrospective study of immunochemical fecal occult blood testing for colorectal cancer detection, Clinica Chimica Acta, 2010, 411, 11-12, 802

   CrossRef

10. 10
    F. A. OORT, J. S. TERHAAR SIVE DROSTE, R. W. M. VAN DER HULST, H. A. VAN HEUKELEM, R. J. L. F. LOFFELD, I. C. E. WESDORP, R. L. J. VAN WANROOIJ, L. DE BAAIJ, E. R. MUTSAERS, S. VAN DER REIJT, V. M. H. COUPE, J. BERKHOF, A. A. BOUMAN, G. A. MEIJER, C. J. J. MULDER, Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test, Alimentary Pharmacology & Therapeutics, 2010, 31, 3

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(150K)
    • References
11. 11
    Dong Il Park, Seungho Ryu, Young-Ho Kim, Suck-Ho Lee, Chang Kyun Lee, Chang Soo Eun, Dong Soo Han, Comparison of Guaiac-Based and Quantitative Immunochemical Fecal Occult Blood Testing in a Population at Average Risk Undergoing Colorectal Cancer Screening, The American Journal of Gastroenterology, 2010, 105, 9, 2017

    CrossRef

12. 12
    Catherine Lejeune, Vincent Dancourt, Patrick Arveux, Claire Bonithon-Kopp, Jean Faivre, Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test, International Journal of Technology Assessment in Health Care, 2010, 26, 01, 40

    CrossRef

13. 13
    Hermann Brenner, Ulrike Haug, Sabrina Hundt, Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests, International Journal of Cancer, 2010, 127, 7

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(144K)
    • References
14. 14
    Leonie van Dam, Ernst J. Kuipers, Monique E. van Leerdam, Performance improvements of stool-based screening tests, Best Practice & Research Clinical Gastroenterology, 2010, 24, 4, 479

    CrossRef

15. 15
    Hongha T. Vu, Carol A. Burke, Advances in colorectal cancer screening, Current Gastroenterology Reports, 2009, 11, 5, 406

    CrossRef

16. 16
    L Guittet, V Bouvier, N Mariotte, J P Vallee, R Levillain, J Tichet, G Launoy, Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location, British Journal of Cancer, 2009, 100, 8, 1230

    CrossRef

17. 17
    Leo G.M. van Rossum, Anne F. van Rijn, Martijn G.H. van Oijen, Paul Fockens, Robert J.F. Laheij, Andre L.M. Verbeek, Jan B.M.J. Jansen, Evelien Dekker, False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening, International Journal of Cancer, 2009, 125, 4

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(149K)
    • References
18. 18
    G. Launoy, Les progrès du dépistage du cancer colorectal liés à l’utilisation des nouveaux tests immunologiques de recherche de sang dans les selles, Pathologie Biologie, 2009, 57, 6, 488

    CrossRef

19. 19
    Lydia Guittet, Véronique Bouvier, Nicole Mariotte, Jean-Pierre Vallee, Romuald Levillain, Jean Tichet, Guy Launoy, Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples, International Journal of Cancer, 2009, 125, 5

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(151K)
    • References
20. 20
    Yogesh M. Shastri, Stefan Loitsch, Nicolas Hoepffner, Nada Povse, Ernst Hanisch, Wolfgang Rösch, Joachim Mössner, Jürgen M. Stein, Comparison of an Established Simple Office-Based Immunological FOBT With Fecal Tumor Pyruvate Kinase Type M2 (M2-PK) for Colorectal Cancer Screening: Prospective Multicenter Study, The American Journal of Gastroenterology, 2008, 103, 6, 1496

    CrossRef

21. 21
    Germaine Wong, Kirsten Howard, Jonathan C. Craig, Jeremy R. Chapman, Cost-Effectiveness of Colorectal Cancer Screening in Renal Transplant Recipients, Transplantation, 2008, 85, 4, 532

    CrossRef

22. 22
    Jürgen Stein, Stefan M. Loitsch, Yogesh Shastri, Nicht-invasive Diagnostik kolorektaler Tumore – Hat der Guaiac-Test ausgedient? / Non-invasive detection of colorectal cancer – do we still need the guaiac-based fecal occult blood test?, LaboratoriumsMedizin, 2008, 32, 3, 158

    CrossRef

23. 23
    Jürgen Stein, Stefan M. Loitsch, Yogesh Shastri, Non-invasive detection of colorectal cancer – do we still need the guaiac-based fecal occult blood test? 1, LaboratoriumsMedizin, 2008, 32, 3, -

    CrossRef

24. 24
    Leo G. van Rossum, Anne F. van Rijn, Robert J. Laheij, Martijn G. van Oijen, Paul Fockens, Han H. van Krieken, Andre L. Verbeek, Jan B. Jansen, Evelien Dekker, Random Comparison of Guaiac and Immunochemical Fecal Occult Blood Tests for Colorectal Cancer in a Screening Population, Gastroenterology, 2008, 135, 1, 82

    CrossRef

25. 25
    Jean-François Bretagne, Sylvain Manfredi, Denis Heresbach, Dépistage de masse du cancer colorectal: présent et avenir, La Presse Médicale, 2007, 36, 7-8, 1054

    CrossRef

26. 26
    G Castiglione, C B Visioli, S Ciatto, G Grazzini, A G Bonanomi, T Rubeca, P Mantellini, M Zappa, Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme, British Journal of Cancer, 2007, 96, 11, 1750

    CrossRef

27. 27
    Graeme P. Young, Molecular approaches to stool screening for colorectal cancer, Current Colorectal Cancer Reports, 2006, 2, 1, 30

    CrossRef

28. 28
    Yogesh M. Shastri, Marc Naumann, Gerhard M. Oremek, Ernst Hanisch, Wolfgang Rösch, Joachim Mössner, Wolfgang F. Caspary, Jürgen M. Stein, Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasia, International Journal of Cancer, 2006, 119, 11

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(136K)
    • References
29. 29
    Célia Berchi, Jean-Marc Dupuis, Guy Launoy, The reasons of general practitioners for promoting colorectal cancer mass screening in France, The European Journal of Health Economics, 2006, 7, 2, 91

    CrossRef

30. 30
    D. Heresbach, S. Manfredi, J. F. Bretagne, Stratégies de dépistage du cancer colorectal: endoscopie versus autres modes d’exploration, Acta Endoscopica, 2005, 35, 4, 621

    CrossRef